We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.24%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$55.2B
AUM Growth
+$1.23B
(+2.3%)
Cap. Flow
-$3.83B
Cap. Flow
% of AUM
-6.94%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
2,357
New
126
Increased
872
Reduced
1,099
Closed
169
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$154M |
| 2 |
ConocoPhillips
COP
|
+$127M |
| 3 |
Chevron
CVX
|
+$111M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$107M |
| 5 |
NRG Energy
NRG
|
+$83.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$376M |
| 2 |
Meta Platforms (Facebook)
META
|
+$195M |
| 3 |
Target
TGT
|
+$191M |
| 4 |
Elevance Health
ELV
|
+$139M |
| 5 |
Amazon
AMZN
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.19% |
| 2 | Healthcare | 15.68% |
| 3 | Industrials | 12.36% |
| 4 | Financials | 11.55% |
| 5 | Consumer Discretionary | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUNA
2076
DELISTED
Luna Innovations Incorporated
LUNA
| $213K | ﹤0.01% |
25,184
+1,689
| +7% | +$15.2K |
|
2077
Amalgamated Financial
AMAL
$1.48B
| $212K | ﹤0.01% |
12,618
| – | – |
|
|
CVGW
2078
DELISTED
Calavo Growers
CVGW
| $211K | ﹤0.01% |
+4,977
| New | +$204K |
|
2079
PTC Therapeutics
PTCT
$6.23B
| $208K | ﹤0.01% |
+5,227
| New | +$200K |
|
2080
Silicon Laboratories
SLAB
$7.2B
| $208K | ﹤0.01% |
+1,009
| New | +$186K |
|
|
GBT
2081
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $208K | ﹤0.01% |
+7,091
| New | +$220K |
|
2082
Quantum Corp
QMCO
$464M
| $207K | ﹤0.01% |
1,879
+991
| +112% | +$113K |
|
2083
Shenandoah Telecom
SHEN
$737M
| $207K | ﹤0.01% |
+8,126
| New | +$228K |
|
2084
Establishment Labs
ESTA
$2.21B
| $204K | ﹤0.01% |
3,024
-429
| -12% | -$30K |
|
|
PAE
2085
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $204K | ﹤0.01% |
20,514
-3,450
| -14% | -$30.8K |
|
2086
BioMarin Pharmaceuticals
BMRN
$13.3B
| $203K | ﹤0.01% |
2,301
-1,054
| -31% | -$87K |
|
2087
Clearwater Paper
CLW
$368M
| $203K | ﹤0.01% |
+5,537
| New | +$221K |
|
2088
Cardiff Oncology
CRDF
$80.1M
| $200K | ﹤0.01% |
33,277
-2,776
| -8% | -$16.5K |
|
2089
Douglas Elliman
DOUG
$166M
| $196K | ﹤0.01% |
+17,869
| New | +$201K |
|
2090
Century Casinos
CNTY
$33.8M
| $195K | ﹤0.01% |
15,997
-7,010
| -30% | -$98.6K |
|
2091
Celcuity
CELC
$4.43B
| $194K | ﹤0.01% |
14,692
-35,042
| -70% | -$561K |
|
|
NGM
2092
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $194K | ﹤0.01% |
10,975
-8,865
| -45% | -$170K |
|
2093
Cars.com
CARS
$653M
| $193K | ﹤0.01% |
12,000
-84,506
| -88% | -$1.21M |
|
|
ZYXI
2094
DELISTED
Zynex
ZYXI
| $193K | ﹤0.01% |
21,328
+7,030
| +49% | +$78K |
|
2095
American Well
AMWL
$231M
| $191K | ﹤0.01% |
1,584
| – | – |
|
|
KG
2096
Kestrel Group
KG
$67.3M
| $190K | ﹤0.01% |
3,112
+381
| +14% | +$24.1K |
|
|
TACO
2097
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $190K | ﹤0.01% |
15,237
-214,064
| -93% | -$2.07M |
|
2098
VistaGen Therapeutics
VTGN
$11.7M
| $188K | ﹤0.01% |
3,220
-2,828
| -47% | -$184K |
|
2099
Archrock
AROC
$5.81B
| $187K | ﹤0.01% |
25,047
-27,766
| -53% | -$223K |
|
2100
Akebia Therapeutics
AKBA
$234M
| $185K | ﹤0.01% |
81,774
+9,004
| +12% | +$24.6K |
|
Similar funds
VGA
AQR Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, AQR Capital Management held 2,357 positions worth $55.2B, up 2.3% from $53.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
AQR Capital Management withdrew a net $3.83B in Q4 2021, closing 169 positions and reducing 1,099 holdings. Its most notable exit was Kansas City Southern, an estimated $7.54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, AQR Capital Management opened a new position in Live Nation Entertainment worth $8.76M.
- AQR Capital Management's largest Q4 2021 buy was Live Nation Entertainment: 73,147 shares worth $8.76M.
- AQR Capital Management added most to Tesla in Q4 2021, an estimated $154M increase.
- AQR Capital Management's biggest Q4 2021 reduction was Apple, cutting an estimated $376M.
- AQR Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $7.54M.
- AQR Capital Management's ten largest holdings make up 17% of its $55.2B portfolio in Q4 2021.
- AQR Capital Management opened 126 new positions and closed 169 in Q4 2021.
- AQR Capital Management's portfolio value rose 2.3% quarter-over-quarter to $55.2B.
Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.